Prostaglandins act as neurotoxin for differentiated neuroblastoma cells in culture and increase levels of ubiquitin and β-amyloid

In Vitro Cellular and Developmental Biology - Animal

Volumn 34, Issue 3, 1998, Pages 265-274

  Prasad, Kedar N ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

cAMP; Differentiation; Neuroblastoma; Ubiquitin; amyloid

Indexed keywords

4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; AMYLOID BETA PROTEIN; ANTIBODY; NEUROTOXIN; PROSTAGLANDIN; UBIQUITIN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MOUSE; NERVE CELL DEGENERATION; NEUROBLASTOMA CELL; NONHUMAN;

ANIMALIA;

EID: 0032452164     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11626-998-0133-7     Document Type: Article

References (17)

1. Aisen, P. S.; Davis, K. L. Inflammatory mechanisms in Alzheimer's disease: implication for therapy. Am. J. Psychol. 151:1105-1113; 1994.
2. Berkenbosch, F.; Biewenga, J.; Brouns, M., et al. Cytokines and inflammatory proteins in Alzheimer's disease. Res. Immunol. 143:657-663; 1992.
3. Breitner, J. C. S.; Gau, B. A.; Welsh, K. A., et al. Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology 41:227-232; 1994.
4. Broe, G. A.; Henderson, A. S.; Creasey, H., et al. A case-control study of Alzheimer's disease in Australia. Neurology 40:1698-1707; 1990.
5. Butterfield, D. A.; Hensley, K.; Harris, M., et al. β-amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implication to Alzheimer's disease. Biochem. Biophys. Res. Commun. 200:710-715; 1994.
6. Cacabelos, R.; Alvarez, X. A. Brain interleukin-1 beta in Alzheimer's disease and vascular dementia. Methods and finding. Exp. Clin. Pharmacol. 16:141-151; 1994.
7. Clemens, J. A.; Stephenson, D. T. Implants containing β-amyloid protein are not neurotoxic to young and old rat brain. Neurobiol. Aging 13:581-586; 1992.
8. Davis, J. B.; McMurray, H. F.; Schubert, D. The amyloid beta-protein of Alzheimer's disease is chemotactic for mononuclear phagocytes. Biochem. Biophys. Res. Commun. 189:1096-1100; 1992.
9. Dewji, N. N.; Singer, S. J. Specific transcellular binding between membrane proteins crucial to Alzheimer disease. Proc. Natl. Acad. Sci. USA 93:12575-12580; 1996.
10. Dickson, D. W.; Lee, S. C.; Mattiace, L. A., et al. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7:75-53; 1993.
11. Doherty, F.; Osborn, N. U.; Wassel, J. A., et al. Ubiquilin-protein conjugates accumulate in the lysosome system of fibroblasts treated with cysteine proteinase inhibitors. Biochem. J. 623:47-55; 1989.
12. Eikelenboom, P.; Zhan, S.-S.; Van gool, W. A., et al. Inflammatory mechanisms in Alzheimer's disease. Trends Pharmacol. Sci. 15:447-450; 1994.
13. Ershler, W. B. Interleukin-6: a cytokine for gerontologists. J. Am. Geriatr. Soc. 41:176-181; 1993.
14. Evans, P. H. Free radicals in brain metabolism and pathology. Brit. Med. Bull. 49:577-587; 1993.
15. Fried, V. A.; Smith, H. T.; Hilderbrandt, E., et al. Ubiquitin has intrinsic proteolytic activity; implications for cellular regulation. Proc. Natl. Acad. Sci. USA 81:3685-3689; 1987.
16. Games, D.; Khan, K. M.; Soriano, F. G., et al. Lack of Alzheimer pathology after β-amyloid protein injections in rat brain. Neurobiol. Aging 13:569-576; 1992.
17. Yoshikawa, K.; Aizawa, T.; Hayashi, Y. Degeneration in vitro of post-mitotic neurons overexpressing the Alzheimer's amyloid protein precursor. Nature 359:61-67; 1992.